---
figid: PMC4667861__BPH-172-5489-g001
figtitle: Signalling pathways and mechanisms regulated by vagal activation
organisms:
- NA
pmcid: PMC4667861
filename: BPH-172-5489-g001.jpg
figlink: /pmc/articles/PMC4667861/figure/bph13010-fig-0001/
number: F1
caption: Schematic representation of signalling pathways and mechanisms regulated
  by vagal activation. The mechanisms contributing to the beneficial effect of improved
  vagal activity are multifactorial, including (1) its anti‐inflammatory effects by
  activating JAK2/STAT pathway and inhibiting NF‐κB activation which is dependent
  upon α7nACh receptor; (2) mitochondrial improvement (increasing mitochondrial biogenesis
  and function, mitochondrial KATP activation and inhibiting mitochondrial permeability
  transition pore (mPTP) opening); (3) redox state regulation (suppressing ROS generation
  and promoting ROS elimination); (4) increase in NO through PI3K/Akt/eNOS pathway;
  (5) down‐regulation of calcium overload. SOD2, Mn superoxide dismutase.
papertitle: Novel strategies and underlying protective mechanisms of modulation of
  vagal activity in cardiovascular diseases.
reftext: Xi He, et al. Br J Pharmacol. 2015 Dec;172(23):5489-5500.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9666756
figid_alias: PMC4667861__F1
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC4667861__F1
ndex: e8b2ea5a-dece-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4667861__BPH-172-5489-g001.html
  '@type': Dataset
  description: Schematic representation of signalling pathways and mechanisms regulated
    by vagal activation. The mechanisms contributing to the beneficial effect of improved
    vagal activity are multifactorial, including (1) its anti‐inflammatory effects
    by activating JAK2/STAT pathway and inhibiting NF‐κB activation which is dependent
    upon α7nACh receptor; (2) mitochondrial improvement (increasing mitochondrial
    biogenesis and function, mitochondrial KATP activation and inhibiting mitochondrial
    permeability transition pore (mPTP) opening); (3) redox state regulation (suppressing
    ROS generation and promoting ROS elimination); (4) increase in NO through PI3K/Akt/eNOS
    pathway; (5) down‐regulation of calcium overload. SOD2, Mn superoxide dismutase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - nAChRbeta1
  - nAChRalpha1
  - mAChR-A
  - SNF4Agamma
  - AMPKalpha
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - lic
  - p38b
  - Nurf-38
  - Ebp
  - AIMP2
  - p38a
  - Hrb87F
  - p38c
  - Nox
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - Akt
  - Sod2
  - Dif
  - dl
  - Rel
  - srl
  - TFAM
  - egr
  - ca
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - CRK
  - MAPK14
  - MAPK1
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - AKT1
  - AKT2
  - AKT3
  - NOS3
  - ENO4
  - SOD2
  - SOD2-OT1
  - STAT3
  - NFKB1
  - PPARGC1A
  - NKRF
  - TNF
  - Cancer
---
